ALS Patients and Researchers Unite in Boston for 4th Annual Leaders... ( Panel of ALS Researchers to Prese...)

ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit

Date:9/24/2008

Panel of ALS Researchers to Present and Consider the Latest Therapeutic Approaches

CAMBRIDGE, Mass., Sept. 24 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced the line-up for its upcoming, annual ALS research symposium, part of the fourth annual ALS TDI Leadership Summit. The symposium will take place this October 20th at the Beacon Hill Holiday Inn in Boston, Mass. A diverse panel of scientists will provide presentations on the development of effective treatments, or a cure, for amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease). After each presentation, audience members are invited to offer comments and ask questions regarding the research. Several of the guest speakers will participate in a panel discussion to take place between the morning and afternoon sessions. The entire event is being offered free of charge by ALS TDI.

"There is a need in the ALS community for openness and directness when it comes to describing what is done with all the monies donated for research. Providing unbiased access to information and researchers is one of the pillars of the ALS TDI philosophy. This annual event provides a unique setting for patients and researchers to connect in pursuit of a shared goal," said John McCarty, Ph.D., Director of Therapeutic Investigation at ALS TDI.

The following is a list of confirmed researchers and proposed presentation topics:

-- "Our Plan, Our Progress, Your Lab," Sean Scott, President, ALS

TDI, Cambridge, Mass.;

-- "The MDA Commitment," Sharon Hesterlee, Ph.D., Vice President

for Translational Research, Muscular Dystrophy Association, Tucson,

Ariz.;

-- "Towards defining the molecular basis of ALS: clues from

TDP-43," Michael J. Strong, M.D., Co-Chair, Department of Clinical

Neurological Sciences, Arthur J. Hudson Chair in ALS Research, London

Health Sciences Centre, Londo
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist
2. Hormone Therapy Not Best for Older Prostate Cancer Patients
3. Whole brain radiation increases risk of learning and memory problems in cancer patients
4. Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
5. Book Proceeds Help Cancer Patients at Phoenix Childrens Hospital
6. Strategies for preventing gastrointestinal complications in severely burned patients
7. The prevalence of hepatitis B virus infection in inflammatory bowel disease patients
8. How to treat gastroesophageal adenocarcinom patients?
9. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
10. Web Site Helps Cancer Patients With Fertility Preservation
11. Girling Health Care Employees and Patients Urged to Call for Instructions

Post Your Comments:

ALS Patients and Researchers Unite in Boston for 4th Annual Leaders...( Panel of ALS Researchers to Prese...),Health